GlassScriptPhysician profile
Izabela Tarasiewicz
NPI 1629123682
$31,297.10
in general payments reported to CMS, 2019-2025
6 companies · $4,867 in 2025
The $4,867 reported for 2025 was more than what 80% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2022: $82.85 · 2023: $1,971 · 2024: $24K · 2025: $4,867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Travel and Lodging: $3,820 · Food and Beverage: $1,388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,724.00 |
| Travel and Lodging | $3,819.51 |
| Food and Beverage | $1,387.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aesculap, INC. | $30,514.33 | 2022-2025 | Paedigav, Surgical Asset Management Sam, Progav 2.0 |
| Kls-Martin L.P. | $317.39 | 2019-2023 | |
| Alafair Biosciences, INC. | $193.25 | 2024-2025 | Versawrap |
| Kuros Biosciences USA, INC | $126.77 | 2024 | Magnetos |
| Medtronic USA, INC. | $86.49 | 2019 | |
| Nico Corporation | $58.87 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Izabela Tarasiewicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.